SuppreMol GmbH

SuppreMol GmbH is a private biotechnology company located in Martinsried near Munich, Germany, and is focused on the development of novel therapeutics for the treatment of autoimmune diseases. In particular the Company is focused on the development of soluble Fc?-Receptors (sFcRs) which are recombinant autologous therapeutic proteins endowed with a proven strong immunosuppressive potential. SuppreMol will develop sFcR as a therapeutic for autoimmune diseases such as Idiopathic Thrombocytopenic Purpura in the first instance and then Systemic Lupus Erythematosus, and Rheumatoid Arthritis. In addition, the Company also has two additional programs to develop an anti-Fc?RIIb monoclonal antibody and small molecules to target Fc?R receptors. The Company was founded in 2002 as a spin-off from the Max-Planck-Institute of Biochemistry in Martinsried/Germany

Contact Details: Am Klopferspitz 19 Martinsried Munich 82152 Germany Tel: 49-89-309050 68-0 Fax: 49-89-309050 68-13 Email: info@suppremol.com WWW: www.suppremol.com/

BioNews Results for SuppreMol GmbH:
SuppreMol Announces Expansion of its Management Team and Board Changes	Pharma Live:  Oct 21 2008 6:54PM Matching: suppremol gmbh

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 252 times since April 2007, the link to the organisation's website has been followed 59 times

Recent Search Terms used to find this page: suppremol press release | recombinant autologous soluble Fc receptors | suppremol | suppremol | suppremol | .

Search for more companies in Martinsried

Search for more companies in Munich

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for SuppreMol GmbH